![Frontiers | Multifaceted Functions and Novel Insight Into the Regulatory Role of RNA N6-Methyladenosine Modification in Musculoskeletal Disorders Frontiers | Multifaceted Functions and Novel Insight Into the Regulatory Role of RNA N6-Methyladenosine Modification in Musculoskeletal Disorders](https://www.frontiersin.org/files/Articles/577876/fcell-08-00870-HTML-r1/image_m/fcell-08-00870-g001.jpg)
Frontiers | Multifaceted Functions and Novel Insight Into the Regulatory Role of RNA N6-Methyladenosine Modification in Musculoskeletal Disorders
An epigenetic regulator-related score (EpiScore) predicts survival in patients with diffuse large B cell lymphoma and identifies patients who may benefit... | Oncotarget
![B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas | Journal of Medicinal Chemistry B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.2c01433/asset/images/medium/jm2c01433_0019.gif)
B-cell Lymphoma 6 Inhibitors: Current Advances and Prospects of Drug Development for Diffuse Large B-cell Lymphomas | Journal of Medicinal Chemistry
![Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets | Cell Death & Differentiation Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets | Cell Death & Differentiation](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fcdd.2016.116/MediaObjects/41418_2017_Article_BFcdd2016116_Fig1_HTML.jpg)
Differential contribution of the mitochondrial translation pathway to the survival of diffuse large B-cell lymphoma subsets | Cell Death & Differentiation
![Small-molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in CML cells overcomes BCR-ABL-independent TKI resistance | Leukemia Small-molecule inhibitor targeting the Hsp70-Bim protein–protein interaction in CML cells overcomes BCR-ABL-independent TKI resistance | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41375-021-01283-5/MediaObjects/41375_2021_1283_Fig1_HTML.png)